IRICoR: a unique model

For the annual edition of the Canadian Society for Pharmaceutical Sciences (CSPS) and the Canadian Chapter of the Controlled Release Society (CC-CRS) conferences, Mrs. Nadine Beauger, Chief Executive Officer at the Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR), was invited to present her organization’s model as Université de Montréal’s key drug discovery and project maturation cluster for academic research based at IRIC. This year’s conference topic is: From Innovation to Patient Solution.

Mrs. Beauger will address the audience during a segment dedicated to innovation and the development of leading edge pharmaceuticals. She will explain the research process for drug discovery towards the development of therapies in partnership with the pharmaceutical industry and how to make the most of it.

For more details, click here:

© 2008-2023 IRICoR